跳至主要内容
临床试验/CTRI/2024/12/077617
CTRI/2024/12/077617尚未招募4 期

Evaluation of the safety & efficacy of Zandu Chyawanprash debility & symptoms associated with weak immunity

Emami Ltd1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2024年12月19日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
50
试验地点
1
主要终点
Kasa - Cough symptom score

研究概览

简要总结

Zandu Chyawanprash is a Classical Ayurvedic medicine and traditional poly-herbal Rasayana formulation marketed in India from decades for the management of general debility and symptoms associated with weak immunity. To further validate these findings, we intend to evaluate the efficacy and safety of this product using clinical parameters. The study’s objective is to validate the clinical efficacy of Zandu Chyawanprash on the basis of scientific parameters and to evaluate the safety of Zandu Chyawanprash. The study will be conducted at Main Campus, Faculty of Ayurveda, Uttarakhand Ayurved Hospital, Harrawala.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Subject having any three symptoms among Kasa (Cough), Svarabheda (Hoarseness of voice), Agnimandya (Digestive impairment), Smritidaurbalya (Cognitive issues), Daurbaly (Weak strength, stamina & low energy), Kshin Anamaya (Weak immunity – Frequent illness such as common cold, body ache), Apraharsh (decreased vigour) Age- 18 years- 65 Years of either sex Co-operative and fully conscious.

排除标准

  • Diabetes mellitus, Severe bronchial Asthma /COPD, Any symptomatic cardiac disease, Chronic debilitating conditions like hepatic/ renal insufficiency Carcinogenic condition (Confirmed through history/clinical examination), Any acute illness/ serious illness, Fever/ delirium, hypertension, Known hypersensitivity or allergy to one or more of the herbal ingredients, Recent (less than 1 month) participation in a clinical trial, Recent (less than 1 month) use of any Herbal/Ayurvedic drugs, Other debilitating neurological or psychiatric disorders, Any condition likely to hinder the compliance with the protocol.

结局指标

主要结局

Kasa - Cough symptom score

时间窗: Day 0, Day 30, Day 60, Day 75

Agnimandya - Severity of the symptoms of indigestion on the basis of Likert scale

时间窗: Day 0, Day 30, Day 60, Day 75

Smritidaurbalya – Verbal recall

时间窗: Day 0, Day 30, Day 60, Day 75

Daurbalyata - Visual Analouge Scale score

时间窗: Day 0, Day 30, Day 60, Day 75

Kshin Anamay (Weak immunity) – History of frequent illness

时间窗: Day 0, Day 30, Day 60, Day 75

Stress & Anxiety – Hamilton anxiety rating scale

时间窗: Day 0, Day 30, Day 60, Day 75

次要结局

  • Hemoglobin, TLC, DLC, ESR, SGPT, SGOT, Urea, Creatinine, FBS(Day 0, Day 30, Day 60)

研究者

发起方
Emami Ltd
申办方类型
Pharmaceutical industry-Indian
责任方
Principal Investigator
主要研究者

Prof Radha Ballabh Sati

Uttarakhand Ayurved University, Faculty of Ayurveda, Main Campus, OPD no. 11

研究点 (1)

Loading locations...

相似试验